Recombinant alpha2 interferon-related cardiomyopathy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (15)
Interferons in the treatment of human cancer.
1984 • 334 citations
Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a Interferon
1984 • 286 citations
Recombinant alfa interferon in renal cell carcinoma: a randomized trial of two routes of administration.
1987 • 165 citations
The alpha interferons: clinical overview.
1987 • 77 citations
A phase I clinical trial of recombinant DNA gamma interferon.
1987 • 46 citations
Alpha-2-interferon/melphalan/prednisone in previously untreated patients with multiple myeloma: a phase I-II trial.
1986 • 44 citations
Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
1985 • 41 citations
Interferon Inhibits Cardiac Cell Function in Vitro
1981 • 38 citations
Deaths Halt Interferon Trials in France
1982 • 34 citations
Reversible arrhythmias observed in patients treated with recombinant alpha2 interferon
1987 • 26 citations
Alpha(human leukocyte)-interferon as treatment for non-small cell carcinoma of the lung: a phase II trial.
1983 • 22 citations
Phase-I trial of Ultrapure? human leukocyte interferon in human malignancy
1984 • 22 citations
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.
1986 • 13 citations
Hyponatremia and other toxic effects during a phase I trial of recombinant human gamma interferon and vinblastine.
1986 • 11 citations
Immunological defects precursors of myocarditis and dilated cardiomyopathy?
1985 • 10 citations